Di Liu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- Cancer, Lipids, and Metabolism 7
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 11
- RNA modifications and cancer 9
- Cancer-related gene regulation 7
-
- Ferroptosis and cancer prognosis 11
- Renal cell carcinoma treatment 6
- Pharmacology top 10%
- Biochemistry top 10%
-
- Genetic Associations and Epidemiology 4
- Co-authors
- Xiaoping ZhangHongmei YangTianbo XuYuanming ZhangJiancheng HuangGuangting HanKe ChenHailong Ruan
- Journals
- Clinical Cancer Research (1 paper)Chemical Engineering Journal (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Di Liu
67 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 347
- Molecular Biology 695
- Pulmonary and Respiratory Medicine 297
- Pharmacology 76
- Biochemistry 54
Countries citing papers authored by Di Liu
This map shows the geographic impact of Di Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Liu more than expected).
Fields of papers citing papers by Di Liu
This network shows the impact of papers produced by Di Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Liu. The network helps show where Di Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Di Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 45 | |
| 12 | 2019 | 24 | |
| 13 | 2019 | 19 | |
| 14 | 2019 | 23 | |
| 15 | 2018 | 26 | |
| 16 | 2018 | 4 | |
| 17 | 2018 | 36 | |
| 18 | 2014 | 13 | |
| 19 | 2014 | 6 | |
| 20 | Isoflavones from Astragalus membranaceus | 1997 | 8 |
About Di Liu
Di Liu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 70 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (11 papers), Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers), Cancer-related gene regulation (7 papers), Cancer, Lipids, and Metabolism (7 papers), Renal cell carcinoma treatment (6 papers) and Genetic Associations and Epidemiology (4 papers). The work is most often cited by research in Cancer Research (347 citations), Molecular Biology (695 citations) and Pulmonary and Respiratory Medicine (297 citations). Di Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoping Zhang, Hongmei Yang, Tianbo Xu, Yuanming Zhang, Jiancheng Huang, Guangting Han, Ke Chen, Hailong Ruan, Lin Bao and Yuenan Liu. Their work appears in journals such as Clinical Cancer Research, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.